Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis

Based on the nationwide survey into inpatients' utilization of the health service covered by China's urban basic medical insurance from 2008 to 2010, we analyzed the use rate, cancer profile and combined use of anticancer Chinese patent medicines (CPMs) on 51,382 insured cancer patients by...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Min, Lu, Peng, Shi, Luwen, Li, Shao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741999/
https://www.ncbi.nlm.nih.gov/pubmed/26513017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741999/
https://www.ncbi.nlm.nih.gov/pubmed/26513017

Ejemplares similares